Vir Biotechnology Inc (VIR)
Inventory turnover
Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
---|---|---|---|---|---|---|
Cost of revenue | US$ in thousands | 845 | 2,765 | 146,319 | 65,865 | 301,579 |
Inventory | US$ in thousands | — | — | — | 8,594 | — |
Inventory turnover | — | — | — | 7.66 | — |
December 31, 2024 calculation
Inventory turnover = Cost of revenue ÷ Inventory
= $845K ÷ $—K
= —
The inventory turnover for Vir Biotechnology Inc was 7.66 times in December 31, 2021. This ratio indicates that the company sold and replaced its inventory 7.66 times during the year. A higher inventory turnover ratio typically suggests efficient inventory management and good sales performance. However, without data for other years, it is difficult to make a trend analysis or comparisons with industry averages. It would be beneficial to monitor this ratio over multiple periods to assess Vir Biotechnology's inventory management effectiveness consistently.
Peer comparison
Dec 31, 2024
Company name
Symbol
Inventory turnover
Vir Biotechnology Inc
VIR
—
ADMA Biologics Inc
ADMA
1.22
Amgen Inc
AMGN
1.84
Bio-Techne Corp
TECH
5.45
Biogen Inc
BIIB
2.09
Gilead Sciences Inc
GILD
3.66
Halozyme Therapeutics Inc
HALO
1.12
Krystal Biotech Inc
KRYS
4.29
Moderna Inc
MRNA
12.51
Neurocrine Biosciences Inc
NBIX
18.20
Repligen Corporation
RGEN
1.78